- Home
- STOK vs FIP Comparison
STOK vs FIP Comparison
Compare STOK & FIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- FIP
- Stock Information
- Founded
- STOK 2014
- FIP 2021
- Country
- STOK United States
- FIP United States
- Employees
- STOK N/A
- FIP N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- FIP Consumer Electronics/Appliances
- Sector
- STOK Health Care
- FIP Industrials
- Exchange
- STOK Nasdaq
- FIP Nasdaq
- Market Cap
- STOK 517.0M
- FIP 495.8M
- IPO Year
- STOK 2019
- FIP N/A
- Fundamental
- Price
- STOK $9.87
- FIP $5.88
- Analyst Decision
- STOK Strong Buy
- FIP Strong Buy
- Analyst Count
- STOK 5
- FIP 2
- Target Price
- STOK $24.50
- FIP $11.50
- AVG Volume (30 Days)
- STOK 694.7K
- FIP 1.6M
- Earning Date
- STOK 05-13-2025
- FIP 05-08-2025
- Dividend Yield
- STOK N/A
- FIP 0.98%
- EPS Growth
- STOK N/A
- FIP N/A
- EPS
- STOK 0.88
- FIP N/A
- Revenue
- STOK $190,908,000.00
- FIP $345,123,000.00
- Revenue This Year
- STOK $44.17
- FIP $65.82
- Revenue Next Year
- STOK $20.00
- FIP $29.85
- P/E Ratio
- STOK $10.88
- FIP N/A
- Revenue Growth
- STOK 2333.81
- FIP 5.70
- 52 Week Low
- STOK $5.35
- FIP $3.10
- 52 Week High
- STOK $17.58
- FIP $10.46
- Technical
- Relative Strength Index (RSI)
- STOK 55.15
- FIP 68.37
- Support Level
- STOK $9.09
- FIP $4.87
- Resistance Level
- STOK $9.83
- FIP $6.41
- Average True Range (ATR)
- STOK 0.61
- FIP 0.32
- MACD
- STOK -0.05
- FIP 0.10
- Stochastic Oscillator
- STOK 51.93
- FIP 78.31
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
About FIP FTAI Infrastructure Inc.
FTAI Infrastructure Inc is engaged in five segments; Railroad segment includes five freight railroads and one switching company that provide rail service to certain manufacturing and production facilities, the Jefferson Terminal segment consists of a multi-modal crude oil and refined products terminal and other related assets. Repauno segment consists of a 1,630-acre deep-water port located along the Delaware River with an underground storage cavern, a new multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities. Power and Gas segment is comprised of an equity method investment in Long Ridge, and Sustainability and Energy Transition segment is comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.